Azitra, Inc. (AZTR)
NYSEAMERICAN: AZTR · Real-Time Price · USD
0.1735
+0.0111 (6.83%)
Sep 17, 2026, 10:54 AM EDT - Market open
Azitra Earnings Call Transcripts
Fiscal Year 2026
-
The company presented its precision dermatology platforms, highlighting engineered skin bacteria and AI-driven drug discovery. Key programs include ATR-04 for EGFR inhibitor-associated rash in phase I/II trials and ATR-COSF for cosmetic use, both with clinical milestones expected later this year.